JPH0735401B2 - Method for producing type I cellulosic acetate - Google Patents

Method for producing type I cellulosic acetate

Info

Publication number
JPH0735401B2
JPH0735401B2 JP26354486A JP26354486A JPH0735401B2 JP H0735401 B2 JPH0735401 B2 JP H0735401B2 JP 26354486 A JP26354486 A JP 26354486A JP 26354486 A JP26354486 A JP 26354486A JP H0735401 B2 JPH0735401 B2 JP H0735401B2
Authority
JP
Japan
Prior art keywords
ctai
cta
solvent
solution
cellulose triacetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP26354486A
Other languages
Japanese (ja)
Other versions
JPS63117001A (en
Inventor
徹 柴田
久雄 西村
剛 清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Original Assignee
Daicel Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daicel Chemical Industries Ltd filed Critical Daicel Chemical Industries Ltd
Priority to JP26354486A priority Critical patent/JPH0735401B2/en
Publication of JPS63117001A publication Critical patent/JPS63117001A/en
Publication of JPH0735401B2 publication Critical patent/JPH0735401B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明は吸着剤、繊維、その他の用途におけるセルロー
ストリアセテートの特性向上に関するものである。更に
詳しくはセルローストリアセテートからI型セルロース
トリアセテート(以下CTAIと略す)を得る方法に関す
る。
DETAILED DESCRIPTION OF THE INVENTION [Field of Industrial Application] The present invention relates to improvement of properties of cellulose triacetate in adsorbents, fibers, and other applications. More specifically, it relates to a method for obtaining type I cellulose triacetate (hereinafter abbreviated as CTAI) from cellulose triacetate.

〔従来の技術及び問題点〕[Conventional technology and problems]

セルローストリアセテート(以下CTAと略す)にはセル
ロースの場合と同様に結晶多形が存在することが知られ
ている。その一つはCTAIと呼ばれるものであり、通常天
然セルロースの不均一アセチル化(反応の過程において
溶解状態を経由しないアセチル化法)によって得られる
が、これは熱力学的には不安定な多形と見做される。即
ちCTAの溶液から沈殿もしくは乾固によって得られるも
のは原則として、II型セルローストリアセテート(以下
CTA IIと略す)と呼ばれ、安定系と見做される多形であ
る。従ってCTAIは一つの例外を除いて溶液系から調製す
ることはできず、このことは原料としての天然セルロー
スのモルホロジー(形態)とは根本的に異なるCTAIを調
製することが困難であることを意味する。CTAIは例えば
吸着特性〔T.Shibata,I.Okamoto,K.Ishii,J.Liq.Chroma
tography,9,313(1986)〕等においてCTA IIとは異なる
特性を示すことが知られている。それ故、溶液からのキ
ャスト、その他の製法によって自由な形状のCTAIを作る
技術が確立されればCTAの応用範囲を更に広げるものに
なる。現在までにCTA溶液からCTAIを得る方法として、
トリフルオロ酢酸を溶媒とする濃厚溶液を水もしくはメ
タノールで凝固する方法が報告されているが、強酸性溶
媒を用いなければならないことなどの制約があった。
Cellulose triacetate (hereinafter abbreviated as CTA) is known to have crystal polymorphism as in the case of cellulose. One of them, called CTAI, is usually obtained by heterogeneous acetylation of natural cellulose (acetylation method that does not go through the dissolved state in the reaction process), which is a thermodynamically unstable polymorph. Is considered. That is, as a rule, what is obtained from the solution of CTA by precipitation or dryness is type II cellulose triacetate (hereinafter
Abbreviated as CTA II), it is a polymorph that is considered to be a stable system. Therefore, with one exception, CTAI cannot be prepared from solution systems, which means that it is difficult to prepare CTAI that is fundamentally different from the morphology of natural cellulose as a raw material. To do. CTAI is, for example, an adsorption property [T. Shibata, I. Okamoto, K. Ishii, J. Liq. Chroma
tography, 9, 313 (1986)] and the like, are known to show different characteristics from CTA II. Therefore, if the technology to make free-form CTAI by casting from solution or other manufacturing methods is established, the range of application of CTA will be further expanded. To date, as a method to obtain CTAI from CTA solution,
Although a method of coagulating a concentrated solution using trifluoroacetic acid as a solvent with water or methanol has been reported, there are restrictions such as the need to use a strongly acidic solvent.

〔問題点を解決するための手段〕[Means for solving problems]

本発明者らは鋭意検討の結果、CTAのフェノール系液体
を溶媒とする溶液を調製し、これを乾固もしくは凝固す
ればCTAIが生成することを見出した。
As a result of intensive studies, the present inventors have found that CTAI is produced by preparing a solution of CTA in a phenolic liquid as a solvent and drying or coagulating the solution.

即ち本発明は、CTAのフェノール系液体を溶媒とする溶
液を乾固もしくは凝固することを特徴とするCTAIの製造
方法に関する。
That is, the present invention relates to a method for producing CTAI, which comprises drying or solidifying a solution of CTA in a phenolic liquid as a solvent.

本発明にいうCTAIとは粉末法X線回折スペクトルによっ
て定義される。参考までに比較的結晶性の高いCTAIとCT
A IIのX線回折スペクトルを第1図及び第2図に示す。
両者の相違は明白であって、CTA IIが回折角2θが8
°、10°及び13°付近の三個のピークと、17°〜19°付
近の集合したピークを特徴とするのに対し、CTAIは7〜
8°、16〜17°のピークを特徴とするので、両者の識別
は容易である。場合によりCTAIとCTA IIのピークが混在
して現れることがあるが、この場合には便宜上CTAIに特
徴的な7〜8°とCTA IIに特徴的な10〜11°の各々のピ
ークの回折強度を比較して、前者の方が強い場合に本発
明にいうCTAIの範疇に属するものとする。
CTAI in the present invention is defined by powder method X-ray diffraction spectrum. For reference, CTAI and CT with relatively high crystallinity
The X-ray diffraction spectrum of A II is shown in FIGS. 1 and 2.
The difference between the two is clear, and the CTA II has a diffraction angle 2θ of 8
The CTAI is characterized by three peaks around °, 10 ° and 13 ° and a set of peaks around 17 ° -19 °, while CTAI is 7-
Since they are characterized by peaks at 8 ° and 16 to 17 °, it is easy to distinguish them. In some cases, CTAI and CTA II peaks may appear together, but in this case, for convenience, the diffraction intensities of the 7-8 ° characteristic of CTAI and the 10-11 ° characteristic of CTA II, respectively. And the former is stronger, it belongs to the category of CTAI referred to in the present invention.

本発明にいうセルローストリアセテート(CTA)とは重
量平均重合度10以上の対応するセルロースの有する水酸
基の90%以上がアセチル化されているものを指す。
The cellulose triacetate (CTA) referred to in the present invention means that 90% or more of the hydroxyl groups of the corresponding cellulose having a weight average polymerization degree of 10 or more are acetylated.

またフェノール系液体とは、フェノール、クレゾール
(o,m,p体)、2,3−ジメチルフェノール、クロロフェノ
ール(o,m,p体)、ブロモフェノール(o,m体)、ヨード
フェノール(o,m体)、フロロフェノール(o,m,p体)
等、融点が60℃以下の液体を指す。
Phenolic liquids include phenol, cresol (o, m, p form), 2,3-dimethylphenol, chlorophenol (o, m, p form), bromophenol (o, m form), iodophenol (o form). , m body), fluorophenol (o, m, p body)
Etc., a liquid having a melting point of 60 ° C. or lower.

本発明の実施に当っては必ずしもフェノール系の液体の
みを溶媒とする必要はなく、これよりも沸点の低い他の
溶媒を混合しても良い。
In carrying out the present invention, it is not always necessary to use only a phenolic liquid as a solvent, and another solvent having a lower boiling point than this may be mixed.

本発明に於いてCTAのフェノール系液体溶液からCTAIを
調製するには、溶媒のフェノール系液体又はこれと他の
溶媒とを適度な減圧下に留去することにより溶液を乾固
又は凝固させれば良い。この場合フェノール系液体を完
全に留去することは難しいが、通常その含量が20%以下
になったものには、CTAIの特徴的なX線回折ピークが現
れ、目的物を得ることができる。
To prepare CTAI from a CTA phenolic liquid solution in the present invention, the solution is dried to solidify or coagulate by distilling off the solvent, which is a phenolic liquid or another solvent, under an appropriate reduced pressure. Good. In this case, it is difficult to completely distill off the phenolic liquid, but normally, when the content is 20% or less, the characteristic X-ray diffraction peak of CTAI appears, and the intended product can be obtained.

一方、CTAに対する非溶剤を用いて沈殿させることも可
能であるが、この方法は特に上記の溶媒留去により得ら
れたCTA含量が十分に高く、既にCTAIの回折パターンを
示しているものからのフェノール系液体の除去において
有効である。この場合CTAに対する膨潤性の低い非溶剤
(例えばヘキサンなど)や、これを主とする混合液(例
えばヘキサン−2−プロパノール混合液)を用いる。
On the other hand, it is also possible to precipitate using a non-solvent for CTA, but this method is particularly high in CTA content obtained by distilling off the above-mentioned solvent, from those already showing the CTAI diffraction pattern. Effective in removing phenolic liquids. In this case, a non-solvent having a low swelling property with respect to CTA (such as hexane) or a mixed liquid mainly containing this (such as hexane-2-propanol mixed liquid) is used.

本発明の方法を用いて製造されるCTAIの形状は、使用目
的によって粒子、繊維、フィルム等いかなるものであっ
ても良く、また担体やCTAと相溶性のない他物質との組
成物とすることもできる。
The shape of CTAI produced using the method of the present invention may be any one such as particles, fibers, and films depending on the purpose of use, and a composition with a carrier or another substance that is not compatible with CTA. You can also

〔作用〕[Action]

本発明の方法においてフェノール系液体がCTAIを生成す
る理由は明らかではないが、恐らく強い溶媒和相互作用
が分子のコンホメーションを変えるか、もしくは高い相
溶性が高濃度の溶液状態を生じ、これが液晶など特殊な
状態をとるため、通常溶液とは異なった結晶格子を結果
するものと考えられる。
It is not clear why the phenolic liquid produces CTAI in the method of the present invention, but it is likely that strong solvation interactions alter the conformation of the molecule, or high compatibility results in a highly concentrated solution state. Since it takes a special state such as liquid crystal, it is thought that it usually results in a different crystal lattice from the solution.

〔発明の効果〕〔The invention's effect〕

本発明の方法により、簡単に、しかも様々な形状のCTAI
を製造することが可能になり、セルロースの有効利用に
役立つものである。
With the method of the present invention, CTAI of various shapes can be easily performed.
It is possible to produce the above, and it is useful for effective utilization of cellulose.

〔実施例〕〔Example〕

以下、本発明を実施例によって具体的に説明するが、本
発明がこれら実施例に限定されるものでないことは言う
までもない。
Hereinafter, the present invention will be specifically described with reference to Examples, but it goes without saying that the present invention is not limited to these Examples.

なお、本実施例のX線回折スペクトルの測定には理学電
機製Geigerflexを用い、スリット幅は各々DS 1/2°、RS
0.15、SS 1/2°を用いた。
Note that Geigerflex manufactured by Rigaku Denki Co., Ltd. was used for the measurement of the X-ray diffraction spectrum in this example, and the slit widths were DS 1/2 ° and RS, respectively.
0.15 and SS 1/2 ° were used.

実施例1 比較的低分子量(クロロホルムを移動相とするGPCによ
って求めたポリスチレン換算分子量は重量平均で9960、
数平均で6500であった)の三酢酸セルロース2g、フェノ
ール660mgをジクロロメタン10mlに溶解し、次いでジク
ロロメタンを減圧乾固した。更に減圧下(0.1mmHg)に8
0℃に加熱し、フェノールの一部を留去した。この処理
により生成した三酢酸セルロースはNMRスペクトルの測
定から19%の残留フェノールを含有した。そのX線回折
スペクトルを第3図に示すが、明らかにCTAIに特徴的な
回折パターンが認められる。
Example 1 Relatively low molecular weight (polystyrene-equivalent molecular weight determined by GPC using chloroform as a mobile phase is 9960 on a weight average,
(The number average was 6500) 2 g of cellulose triacetate and 660 mg of phenol were dissolved in 10 ml of dichloromethane, and then dichloromethane was evaporated to dryness under reduced pressure. 8 under reduced pressure (0.1 mmHg)
It heated at 0 degreeC and some phenols were distilled off. The cellulose triacetate produced by this treatment contained 19% residual phenol as determined by NMR spectroscopy. The X-ray diffraction spectrum is shown in FIG. 3, and the diffraction pattern characteristic of CTAI is clearly observed.

実施例2 実施例1で得られた三酢酸セルロースをヘキサンと2−
プロパノール9:1の混合液で洗滌したところ、フェノー
ルは痕跡量まで除かれたが、得られた三酢酸セルロース
のX線回折スペクトルは実施例1の場合と殆ど変わらな
かった。
Example 2 Cellulose triacetate obtained in Example 1 was mixed with hexane and 2-
When washed with a mixed solution of propanol 9: 1, phenol was removed to a trace amount, but the X-ray diffraction spectrum of the obtained cellulose triacetate was almost the same as that in Example 1.

実施例3 GPC(クロロホルム溶媒)によって求めたポリスチレン
換算分子量が重量平均で166000、数平均分子量が58000
の三酢酸セルロース3gをフェノール2g、ジクロロメタン
30mlに溶解し、実施例1及び実施例2と同様の処理を施
した後、X線回折スペクトルを測定した。得られたスペ
クトルはCTAIに特徴的なものであった。
Example 3 The polystyrene reduced molecular weight determined by GPC (chloroform solvent) was 166,000 on a weight average, and the number average molecular weight was 58,000.
3 g of cellulose triacetate, 2 g of phenol, dichloromethane
After dissolving in 30 ml and applying the same treatment as in Example 1 and Example 2, the X-ray diffraction spectrum was measured. The spectrum obtained was characteristic of CTAI.

【図面の簡単な説明】[Brief description of drawings]

第1図及び第2図は夫々CTAI及びCTA IIのX線回折スペ
クトルを示す図、第3図は実施例1により得られたCTAI
のX線回折スペクトルを示す図である。
1 and 2 show the X-ray diffraction spectra of CTAI and CTA II, respectively, and FIG. 3 shows the CTAI obtained in Example 1.
It is a figure which shows the X-ray diffraction spectrum of.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】セルローストリアセテートのフェノール系
液体を溶媒とする溶液を乾固もしくは凝固することを特
徴とするI型セルローストリアセテートの製造方法。
1. A process for producing type I cellulose triacetate, which comprises drying or coagulating a solution of cellulose triacetate in a phenolic liquid as a solvent.
JP26354486A 1986-11-05 1986-11-05 Method for producing type I cellulosic acetate Expired - Lifetime JPH0735401B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP26354486A JPH0735401B2 (en) 1986-11-05 1986-11-05 Method for producing type I cellulosic acetate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26354486A JPH0735401B2 (en) 1986-11-05 1986-11-05 Method for producing type I cellulosic acetate

Publications (2)

Publication Number Publication Date
JPS63117001A JPS63117001A (en) 1988-05-21
JPH0735401B2 true JPH0735401B2 (en) 1995-04-19

Family

ID=17391012

Family Applications (1)

Application Number Title Priority Date Filing Date
JP26354486A Expired - Lifetime JPH0735401B2 (en) 1986-11-05 1986-11-05 Method for producing type I cellulosic acetate

Country Status (1)

Country Link
JP (1) JPH0735401B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4509239B2 (en) 1998-11-19 2010-07-21 ダイセル化学工業株式会社 Cellulose triacetate and method for producing the same
JP4714107B2 (en) * 2006-08-09 2011-06-29 株式会社小糸製作所 Infrared light irradiation lamp for vehicles

Also Published As

Publication number Publication date
JPS63117001A (en) 1988-05-21

Similar Documents

Publication Publication Date Title
FI81822B (en) Composition for use for producing fibres or films and on the basis of at least one cellulose derivative, a process for producing the composition, and a process for producing an article from the composition
Demetgül et al. Synthesis, characterization and antioxidant activity of chitosan-chromone derivatives
Yin et al. Miscibility studies of the blends of chitosan with some cellulose ethers
Wu et al. A novel biomass-ionic liquid platform for the utilization of native chitin
Cram et al. Host-guest complexation. 35. Spherands, the first completely preorganized ligand systems
Reetz et al. Cross‐Linked Scandium‐Containing Dendrimers: A New Class of Heterogeneous Catalysts
JPH0425505A (en) Cyclodextrain polymer and production of cyclodextrin membrane
Allcock et al. An ionically crosslinkable polyphosphazene: poly [bis (carboxylatophenoxy) phosphazene] and its hydrogels and membranes
JPH0733433B2 (en) New polymer
Wang et al. Novel triblock copolymers comprising a polyrotaxane middle block flanked by PNIPAAm blocks showing both thermo-and solvent-response
NO843773L (en) PROCEDURE FOR PREPARING A CONTAINER COMPOUND OF 2-NITROXYMETHYL-6-CHLORPYRIDINE
JPH0735401B2 (en) Method for producing type I cellulosic acetate
Focher et al. High molecular weight chitosan 6‐O‐sulfate. Synthesis, ESR and NMR characterization
JP3749746B2 (en) Homogeneous cellulose acetate
Kondo et al. Preparation of completely allylated and methallylated celluloses from methylcellulose and cellulose acetate
EP1167391B1 (en) Cellulose triacetate and process for producing the same
JPH0625307A (en) Alpha-cyclodextrin clathrate compound of end-capped guest polymer and method for producing cyclodextrin clathrate compound of end-capped guest polymer
Badawy et al. A study of the complexation between danazol and hydrophilic cyclodextrin derivatives
Shigeno et al. Functional monomers and polymers, 74. Physico‐chemical study on the chitosan‐iodine complexes
Lin et al. Inclusion complexation of warfarin with cyclodextrins to improve some pharmaceutical characteristics
Vakily et al. Inclusion complexation of heptakis (2, 6‐di‐o‐ethyl)‐β‐cyclodextrin with tiaprofenic acid: Pharmacokinetic consequences of a pH‐dependent release and stereoselective dissolution
EP1272531A2 (en) Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
Puglisi et al. Preparation and physico-chemical study of inclusion complexes between idebenone and modified β-cyclodextrins
JPH036921B2 (en)
JP3604390B2 (en) Use of mono-3,6-anhydrocyclodextrins for dissolving hydrophobic compounds and checking the purity of enantiomers and a process for the preparation of these cyclodextrins

Legal Events

Date Code Title Description
S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313532

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term